Back to Search Start Over

Oxidative-phosphorylation defects in liver of patients with Wilson's disease.

Authors :
Gu, M
Cooper, J M
Butler, P
Walker, A P
Mistry, P K
Dooley, J S
Schapira, A H V
Schapira, A H
Source :
Lancet. 8/5/2000, Vol. 356 Issue 9228, p469-474. 6p. 3 Black and White Photographs, 2 Charts.
Publication Year :
2000

Abstract

<bold>Background: </bold>Wilson's disease (WD) is caused by mutations in a P-type ATPase and is associated with copper deposition in liver and brain. The WD protein is present in the trans-Golgi network and may also be imported into mitochondria. The WD protein functions as a P-type copper transporting ATPase in the Golgi but any action in mitochondria is at present unknown.<bold>Methods: </bold>We studied mitochondrial function and aconitase activity in WD liver tissue and compared the results with those in a series of healthy controls and patients without WD.<bold>Findings: </bold>There was evidence of severe mitochondrial dysfunction in the livers of patients with WD. Enzyme activities were decreased as follows: complex I by 62%, complex II+III by 52%, complex IV by 33%, and aconitase by 71%. These defects did not seem to be secondary to penicillamine use, cholestasis, or poor hepatocellular synthetic function.<bold>Interpretation: </bold>The results show that there is a defect of energy metabolism in WD. The pattern of enzyme defects suggests that free-radical formation and oxidative damage, probably mediated via mitochondrial copper accumulation, are important in WD pathogenesis. These results provide a rationale for a study of the use of antioxidants in WD. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
01406736
Volume :
356
Issue :
9228
Database :
Academic Search Index
Journal :
Lancet
Publication Type :
Academic Journal
Accession number :
3394260
Full Text :
https://doi.org/10.1016/S0140-6736(00)02556-3